Dr. Carlos L. Arteaga MD
Oncologist | Medical Oncology
3601 Tvc Nashville TN, 37232About
Dr. Carlos Arteaga is an oncologist practicing in Nashville, TN. Dr. Arteaga specializes in the care and treatment of patients with cancer. As an oncologist, Dr. Arteaga manages and oversees the treatment of a cancer patient after he or she has been diagnosed with the disease. Oncologists will care for their patients throughout the course of the disease. Types of oncologists include medical oncologists, surgical oncologists, radiation oncologists, gynecologic oncologists, pediatric oncologists and hematologist oncologists.
Education and Training
Univ De Guayaquil- Fac De Cien Med- Guayaquil- Ecuador 1979
Universidad De Guayaquil, Facultad De Ciencias Medicas 1980
Board Certification
Internal MedicineAmerican Board of Internal MedicineABIM
Provider Details
Expert Publications
Data provided by the National Library of Medicine- ErbB2/Neu-induced, cyclin D1-dependent transformation is accelerated in p27-haploinsufficient mammary epithelial cells but impaired in p27-null cells.
- Overview of rationale and clinical trials with signal transduction inhibitors in lung cancer.
- Blockade of TGF-beta inhibits mammary tumor cell viability, migration, and metastases.
- p38 mitogen-activated protein kinase is required for TGFbeta-mediated fibroblastic transdifferentiation and cell migration.
- Herceptin-induced inhibition of phosphatidylinositol-3 kinase and Akt Is required for antibody-mediated effects on p27, cyclin D1, and antitumor action.
- Epidermal growth factor receptor dependence in human tumors: more than just expression?
- TGFbeta1 -mediated epithelial to mesenchymal transition is accompanied by invasion in the SiHa cell line.
- PKB/Akt mediates cell-cycle progression by phosphorylation of p27(Kip1) at threonine 157 and modulation of its cellular localization.
- Effects of genetic blockade of the insulin-like growth factor receptor in human colon cancer cell lines.
- Autocrine transforming growth factor-beta signaling mediates Smad-independent motility in human cancer cells.
- Overview of epidermal growth factor receptor biology and its role as a therapeutic target in human neoplasia.
- The tumor microenvironment: a potential arbitrator of the tumor suppressive and promoting actions of TGFbeta.
- A kinase-inactive type II TGFbeta receptor impairs BMP signaling in human breast cancer cells.
- ErbB (HER) receptors can abrogate antiestrogen action in human breast cancer by multiple signaling mechanisms.
- Trastuzumab, an appropriate first-line single-agent therapy for HER2-overexpressing metastatic breast cancer.
Dr. Carlos L. Arteaga MD's Practice location
Dr. Carlos L. Arteaga MD's reviews
Write ReviewPatient Experience with Dr. Arteaga
Recommended Articles
- ‘Bachelor’ Alum Lesley Murphy Shares Picture After Double Mastectomy
At the age of 29, Lesley Murphy was making a living by traveling around the world and sharing her experiences on her blog called ‘The Road Les Traveled’. However, her travels were put to a halt when the travel blogger and Bachelor Alum tested positive for a gene that linked her with a high risk...
- This Ovarian Cancer Survivor Advises Women to Stay True to Themselves
Those who have been through cancer often have some of the best advice on how to live life, as they have come so close to losing their own. This often creates an ability to distinguish what is important and what isn't, and Pam Scarpino now knows what is most important: staying true to oneself.Pam's...
- Finding Breast Cancer's Hiding Place: A New Study
Scientists have often wondered why some patients respond so well to chemotherapy and why some don’t. Some cancers are easier to cure while others have a higher risk of relapse and continued issues. Each cancer is different and every cancer treatment is tailored to the cancer cells it’s...
- Is Leukemia Fatal?
Leukemia is a malignancy, or cancer, of the blood and bone marrow that primarily affects the white blood cells — the blood cells responsible for fighting off infections and other foreign organisms that enter the bloodstream. With leukemia, the bone marrow produces a higher level of immature white...
- Can Ovarian Cancer Screening Cause Harm in Women Without Symptoms?
According to a draft of new guidelines relating to screening, ovarian cancer screening in young women who have no symptoms can cause harm and offers no benefits. According to the U.S. Preventative Services Task Force (USPSTF), the screening is not recommended for many women without symptoms. The...
- Does Bladder Cancer Require Chemotherapy for Treatment?
Does bladder cancer require chemotherapy for treatment?Bladder cancer can be treated through a number of ways and chemotherapy is one of them. Chemotherapy is an important treatment method and it works well in many cases. However, to understand whether it is necessary, it is important to know what...
Nearby Providers
- Dr. Nancy Davis MD3601 THE VANDERBILT CLINIC NASHVILLE TN 37232
- Dr. Julie Means-Powell MD3601 Tvc Nashville TN 37232
- Dr. David Chism MD3601 THE VANDERBILT CLINIC NASHVILLE TN 37232
- Dr. Christopher Edward Fundakowski M.D.3601 Tvc Nashville TN 37232
- Dr. Michael Norbert Neuss M.D.2220 Pierce Avenue, Vanderbilt Ingram Cancer Center Nashville TN 37232
- Dr. Adetola A Kassim MD2665 The Vanderbilt Clinic Nashville TN 37232